SynPeptide operates a dedicated peptide synthesis and manufacturing facility spanning two full floors at Jiangsu Life Science & Technology Innovation Park in Nanjing, China. Our production lines cover the entire peptide workflow — synthesis, purification, lyophilization, and QC testing — all under one roof with no outsourcing at any stage. The facility is equipped with 96-channel automated peptide synthesizers, Waters UPLC and HPLC systems, DAC purification platforms, desktop purification units, and ZLGJ-100 pilot-scale lyophilizers. These systems support peptide synthesis from milligrams to kilograms, at purities up to 98%, with full in-house quality control on every batch. Our R&D team of 30+ scientists brings over 10 years of peptide process development experience. More than 20% of our 150+ staff hold master's or doctoral degrees. With 50+ granted patents in peptide synthesis technology, we maintain independent capability in synthesis route design, analytical method development, process optimization, and scale-up — the full chain from research-grade samples to commercial-scale production.
Complete in-house production line — synthesis, purification, lyophilization, and packaging. 96-channel automated synthesizers, Waters UPLC/HPLC, DAC purification, and pilot-scale lyophilizers. Monthly capacity: 3 kg. Single-batch scale: up to 2 kg. Purity: ≥98%.
30+ peptide scientists with over 10 years of process development experience. 50+ granted patents in synthesis technology. Full in-house capability from sequence design to analytical method development.
